by Bill Malloy | May 23, 2022 | Health, Medication, Pharmaceuticals
In November 2021, a cancer treatment agent called Cytalux was approved by the US Food and Drug Administration (FDA). Between 22,000 and 24,000 women are diagnosed with ovarian cancer each year in the United States. Oncologists are hopeful that this new treatment can...
by Bill Malloy | May 16, 2022 | Health, Medication, Scientists
Colorectal cancer is one of the most common forms of cancer and, as the second-leading cause of cancer deaths, it is also one of the most serious. For years, cancer researchers have been searching for ways to prevent and treat colorectal cancer more...
by Bill Malloy | May 9, 2022 | Health, Pharmaceuticals, Scientists, Uncategorized
A potential cancer immunotherapy treatment has been developed by researchers at Purdue University’s College of Pharmacy. Led by Zhong-Yin Zhang, the researchers are continuing to develop the immunotherapy treatment, which is based on an enzyme mutation. The team of...
by Bill Malloy | Apr 9, 2022 | Uncategorized
Project management company Asana went public in September 2020, and despite some volatility, its value has risen significantly since then. This San Francisco-based tech newcomer’s market arrival was highly anticipated in the industry, and as it continues to grow, it...
by Bill Malloy | Nov 18, 2021 | Uncategorized
Cancer has affected the lives of the majority of Americans. According to a CBS News poll, 54% of Americans have either been diagnosed with cancer themselves, or have a family member who has been diagnosed. Brain cancer is the most common type of cancer among children...
